MAP3K12-Binding Inhibitory Protein 1 (MBIP) (N-Term) Peptide
-
- Target See all MBIP products
- MBIP (MAP3K12-Binding Inhibitory Protein 1 (MBIP))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- EVNDKFSIGD LQEEEKHKES DLRDVKKTQI HFDPEVVQIK AGKAEIDRRI
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-MBIP Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MBIP (MAP3K12-Binding Inhibitory Protein 1 (MBIP))
- Synonyms
- 4933408E06Rik Peptide, MAP3K12 binding inhibitory protein 1 Peptide, Mbip Peptide, mbip Peptide, MBIP Peptide
- Background
-
MBIP inhibits the MAP3K12 activity to induce the activation of the JNK/SAPK pathway. Component of the ATAC complex, a complex with histone acetyltransferase activity on histones H3 and H4.
Alias Symbols: -
Protein Size: 344 - Molecular Weight
- 39 kDa
- Gene ID
- 51562
- NCBI Accession
- NM_016586, NP_057670
- UniProt
- Q9NS73
-